ArticleDrugs in R&D2024

Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism.

Nicola Ferri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.